GSK’s 2016 Annual Report and Responsible Business Supplement

Primary tabs

GSK’s 2016 Annual Report and Responsible Business Supplement

GSK is a science-led global healthcare company. Our mission is to help people do more, feel better and live longer. We do this by researching and developing medicines, vaccines and consumer healthcare products that improve people’s lives. By growing our business and extending access to our medicines, we are ensuring long-term commercial success as well as improving people’s health, creating value for our shareholders and delivering economic benefits to society.

Review our 2016 Annual Report and Responsible Business Supplement

Learn more about GSK’s responsible business practices

Watch our new video series To Challenge. To Change.

Join the conversation on Twitter

Content from this campaign

Fast-Tracking Our Response to Pandemics
In the wake of global pandemics such as Ebola and Zika, there is consensus that the world needs to be better prepared. Finding better ways to prepare ...
Apr 26, 2017 9:00 AM ET
Helping Patients in Need
Insurance coverage can be challenging, financial circumstances can change quickly, and sometimes patients need assistance paying for their prescription medications or vaccines. Helping patients access the GSK medicines and vaccines they need is critically important to us and aligns with our value of being a patient-focused company. Paying for your prescription...
Apr 25, 2017 9:00 AM ET
Evolving Our Graduated Approach to Intellectual Property
In developing countries, millions of people have no access to even the most basic healthcare services, including safe and effective medicines. Increasingly, developing countries are hit with the double burden of infectious diseases such as HIV/AIDS, tuberculosis, and malaria, and the growing problem of...
Apr 24, 2017 9:00 AM ET
Hunting for Energy Savings
You never know what you might find when you hunt for waste. In 2010, we committed to reducing our environmental impact by 2020 in the following ways:  Minimizing our overall carbon footprint by 25% Reducing our water impact across the value chain by 20% Cutting our operational waste by 50% One initiative that helps us deliver on this ambitious...
Apr 22, 2017 10:00 AM ET
Creating Bricks and Benches Out of Medical Waste
There’s no way around it: researching and manufacturing life-saving medicines and vaccines produces waste. At GSK, we are changing our manufacturing processes to cut in half the amount of operational waste we generate by 2020, and shifting our perceptions to see waste as a potential resource. Around the world Our global operations produced 137,000 tons of waste...
Apr 22, 2017 9:00 AM ET

Pages